Septerna, Inc. (SEPN) stock
SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30165% above fair value
$39.45−0.57 (-1.42%)
Close on Nov 18, 2026Market cap $1.84BP/E –Yield –
Septerna revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Septerna's revenue for the twelve months ending Sep 30, 2026 was $96.27M, up 336.7% year over year. For fiscal 2025 it was $45.95M, up 4174.5% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $45.95M | +4174.5% |
| FY2024 | Dec 31, 2024 | $1.08M | +611.9% |
| FY2023 | Dec 31, 2023 | $151.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $18.88M | -12.2% |
| Q2 FY2026 | Jun 30, 2026 | $26.75M | +22375.6% |
| Q1 FY2026 | Mar 31, 2026 | $26.52M | +12011.0% |
| Q4 FY2025 | Dec 31, 2025 | $24.12M | +11276.4% |
| Q3 FY2025 | Sep 30, 2025 | $21.50M | +12113.1% |
| Q2 FY2025 | Jun 30, 2025 | $119.00K | -67.8% |
| Q1 FY2025 | Mar 31, 2025 | $219.00K | -30.9% |
| Q4 FY2024 | Dec 31, 2024 | $212.00K | +79.7% |
| Q3 FY2024 | Sep 30, 2024 | $176.00K | +433.3% |
| Q2 FY2024 | Jun 30, 2024 | $370.00K | – |
| Q1 FY2024 | Mar 31, 2024 | $317.00K | – |
| Q4 FY2023 | Dec 31, 2023 | $118.00K | – |
| Q3 FY2023 | Sep 30, 2023 | $33.00K | – |
See a number that looks wrong?